Research ArticleArticle
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience from the Corrona PsA/SpA Registry
Philip J. Mease, Carol J. Etzel, William J. Huster, April W. Armstrong, Talia M. Muram, Jeffrey Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi J. Murage, Jeffrey D. Greenberg and William N. Malatestinic
The Journal of Rheumatology May 2020, jrheum.190422; DOI: https://doi.org/10.3899/jrheum.190422
Philip J. Mease
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Carol J. Etzel
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
William J. Huster
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
April W. Armstrong
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Talia M. Muram
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Jeffrey Lisse
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Sabrina Rebello
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Rhiannon Dodge
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Mwangi J. Murage
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
Jeffrey D. Greenberg
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
William N. Malatestinic
This study was sponsored by Corrona, LLC. Corrona, LLC has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer Inc., Regeneron, Roche, Merck, UCB, and Valeant. P.J. Mease, MD, MACR, Swedish-Providence-St. John Health Systems, and University of Washington, Seattle, Washington; C.J. Etzel, PhD, S. Rebello, MPH, R. Dodge, MS, Corrona, LLC, Waltham, Massachusetts; W. Huster, PhD, T. Muram, MD, J. Lisse, MD, M.J. Murage, PhD, MPH, W. Malatestinic, PharmD, MBA, Eli Lilly and Company, Indianapolis, Indiana; A. Armstrong, MD, MPH, University of Southern California, Los Angeles, California; J.D. Greenberg, MD, MPH, Corrona, LLC, Waltham, Massachusetts, and New York School of Medicine, New York, New York, USA. PJM has received research grants from Novartis, AbbVie, Amgen, BMS, Janssen, Eli Lilly, Novartis, Pfizer, SUN, and UCB; consultant fees from Abbvie, Amgen, BMS, Celgene, Corrona, Galapagos, Gilead, Janssen, Leo, Eli Lilly, Merck, Novartis, Pfizer, SUN, and UCB; and speakers bureau fees for AbbVie, Amgen, BMS, Genentech, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. AWA has acted as an investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Eli Lilly, Regeneron, Sanofi, Leo, Science 37, Modernizing Medicine, and Ortho Dermatologics. TMM, JL, WNM, MJM, and WJH are employees of and hold stock in Eli Lilly. RD and SR are employees of Corrona, LLC. CJE is an employee and holds stock in Corrona, LLC, and is on the advisory board to Merck. JDG is an employee and holds stock in Corrona, LLC, and is a consultant for Genentech, Janssen, Novartis, Pfizer, and Eli Lilly. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com. Accepted for publication March 20, 2020.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience from the Corrona PsA/SpA Registry
Philip J. Mease, Carol J. Etzel, William J. Huster, April W. Armstrong, Talia M. Muram, Jeffrey Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi J. Murage, Jeffrey D. Greenberg, William N. Malatestinic
The Journal of Rheumatology May 2020, jrheum.190422; DOI: 10.3899/jrheum.190422
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience from the Corrona PsA/SpA Registry
Philip J. Mease, Carol J. Etzel, William J. Huster, April W. Armstrong, Talia M. Muram, Jeffrey Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi J. Murage, Jeffrey D. Greenberg, William N. Malatestinic
The Journal of Rheumatology May 2020, jrheum.190422; DOI: 10.3899/jrheum.190422